Track topics on Twitter Track topics that are important to you
TORONTO, ONTARIO -- (Marketwired) -- 08/06/15 -- Prism Medical Ltd. ("Prism") (TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged, announced that it granted options on August 4, 2015 to acquire 745,000 common shares to directors, senior officers and employees of Prism or its affiliates having a term of three years and an exercise price of $12.06 per share. The options vest one-third on the date of the grant and one-third on each of the first two anniversary dates of the grant and are otherwise subject to the terms of the company's stock option plan.
Prism Medical is a vertically integrated manufacturer and leading provider of equipment and services used to move and handle mobility challenged individuals in a safe and dignified manner. Prism Medical's products are marketed under the brand names of Prism Medical, ErgoSafe, Waverly Glen and Nightingale in the homecare, acute care and long-term care markets throughout North America. The Company offers solutions that encourage improved care, quality of life and mobility, while seeking to lower the overall cost of the caregiving function in a number of ways, including reducing the incidence of handling-related injuries among caregivers. In addition, the Company through its network of Nightingale dealers provides an integrated suite of products and services that make home care a viable option for many people. For further information visit Prism Medical's website at www.prismmedicalltd.com or www.sedar.com.
This document contains forward-looking statements relating to our operations and to the environment in which we operate and our strategy, action plans and investments, which may involve estimates, forecasts and projections. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict and/or are beyond our control. A number of important factors could cause actual outcomes and results to differ materially from those expressed in these forward-looking statements. These factors include those set forth in this report and our other public filings. Consequently, readers should not place any undue reliance on such forward-looking statements. These forward-looking statements are made as of the date of this report. Prism Medical is under no obligation to update any forward-looking statements contained herein should material facts change due to new information, future events or other factors. All forward-looking statements attributable to Prism Medical are expressly qualified by these cautionary statements.
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.Contacts: Prism Medical Ltd. Andy McIntyre Chairman and Chief Executive Officer 416-260-2145 ext. 235 NEXT ARTICLE